Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma

Autor: Shah, Jatin J. *, Stadtmauer, Edward A., Abonour, Rafat, Cohen, Adam D., Bensinger, William I., Gasparetto, Cristina, Kaufman, Jonathan L., Lentzsch, Suzanne, Vogl, Dan T., Gomes, Christina L., Pascucci, Natalia, Smith, David D., Orlowski, Robert Z., Durie, BrianG.M.
Zdroj: In Blood 12 November 2015 126(20):2284-2290
Databáze: ScienceDirect